Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Maiken C. Arendrup"'
Publikováno v:
Journal of Fungi, Vol 8, Iss 10, p 1106 (2022)
Ibrexafungerp is a novel triterpenoid antifungal that inhibits glucan synthase and thus fungal cell wall synthesis. We examined the in vitro activity against contemporary clinical yeast, investigated inter-laboratory and intra-laboratory variability,
Externí odkaz:
https://doaj.org/article/c685deb1556c4dfe879b72b12e94289a
Autor:
Rasmus K. Hare, Jan B. Gertsen, Karen M.T. Astvad, Kristine B. Degn, Anders Løkke, Marc Stegger, Paal S. Andersen, Lise Kristensen, Maiken C. Arendrup
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 3, Pp 577-580 (2019)
We report a fatal aspergillosis case in which STRAf typing and whole-genome sequencing substantiated in vivo emergence of an azole-resistant Aspergillus fumigatus with a 120-bp tandem repeat in the promoter region of cyp51A. This event, previously re
Externí odkaz:
https://doaj.org/article/d183ec7c70df4d2d9e2afabf6c4a9ca2
Autor:
Jesús Guinea, Maiken C. Arendrup, Rafael Cantón, Emilia Cantón, Julio García-Rodríguez, Ana Gómez, Elia Gómez G. de la Pedrosa, Rasmus K. Hare, Beatriz Orden, Maurizio Sanguinetti, Javier Pemán, Brunella Posteraro, Alba Ruiz-Gaitán, Gabriella Parisi, Daniel Archimedes Da Matta, Arnaldo L. Colombo, Carlos Sánchez-Carrillo, Elena Reigadas, Patricia Muñoz, Pilar Escribano
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
The objectives of this study were to gain further insight on Candida genotype distribution and percentage of clustered isolates between hospitals and to identify potential clusters involving different hospitals and cities. We aim to genotype Candida
Externí odkaz:
https://doaj.org/article/39d75e0466e94a7a96e332da4ac50892
Autor:
Patrick Van Dijck, Jelmer Sjollema, Bruno P.A. Cammue, Katrien Lagrou, Judith Berman, Christophe d’Enfert, David R. Andes, Maiken C. Arendrup, Axel A. Brakhage, Richard Calderone, Emilia Cantón, Tom Coenye, Paul Cos, Leah E. Cowen, Mira Edgerton, Ana Espinel-Ingroff, Scott G. Filler, Mahmoud Ghannoum, Neil A.R. Gow, Hubertus Haas, Mary Ann Jabra-Rizk, Elizabeth M. Johnson, Shawn R. Lockhart, Jose L. Lopez-Ribot, Johan Maertens, Carol A. Munro, Jeniel E. Nett, Clarissa J. Nobile, Michael A. Pfaller, Gordon Ramage, Dominique Sanglard, Maurizio Sanguinetti, Isabel Spriet, Paul E. Verweij, Adilia Warris, Joost Wauters, Michael R. Yeaman, Sebastian A.J. Zaat, Karin Thevissen
Publikováno v:
Microbial Cell, Vol 5, Iss 7, Pp 300-326 (2018)
Tuberculosis produces two clinical manifestations: active and latent (non-apparent) disease. The latter is estimated to affect one-third of the world population and constitutes a source of continued transmission should the disease emerge from its hid
Externí odkaz:
https://doaj.org/article/e4a5ef0229644629a26483bb1bd9e174
Autor:
Tamara Zoran, Bettina Sartori, Laura Sappl, Maria Aigner, Ferran Sánchez-Reus, Antonio Rezusta, Anuradha Chowdhary, Saad J. Taj-Aldeen, Maiken C. Arendrup, Salvatore Oliveri, Dimitrios P. Kontoyiannis, Ana Alastruey-Izquierdo, Katrien Lagrou, Giuliana Lo Cascio, Jacques F. Meis, Walter Buzina, Claudio Farina, Miranda Drogari-Apiranthitou, Anna Grancini, Anna M. Tortorano, Birgit Willinger, Axel Hamprecht, Elizabeth Johnson, Lena Klingspor, Valentina Arsic-Arsenijevic, Oliver A. Cornely, Joseph Meletiadis, Wolfgang Prammer, Vivian Tullio, Jörg-Janne Vehreschild, Laura Trovato, Russell E. Lewis, Esther Segal, Peter-Michael Rath, Petr Hamal, Manuel Rodriguez-Iglesias, Emmanuel Roilides, Sevtap Arikan-Akdagli, Arunaloke Chakrabarti, Arnaldo L. Colombo, Mariana S. Fernández, M. Teresa Martin-Gomez, Hamid Badali, Georgios Petrikkos, Nikolai Klimko, Sebastian M. Heimann, Omrum Uzun, Maryam Roudbary, Sonia de la Fuente, Jos Houbraken, Brigitte Risslegger, Raquel Sabino, Cornelia Lass-Flörl, Michaela Lackner
Publikováno v:
Frontiers in Microbiology, Vol 9 (2019)
Externí odkaz:
https://doaj.org/article/6494b983de1b43c394dcf41f161be6e4
Autor:
Tamara Zoran, Bettina Sartori, Laura Sappl, Maria Aigner, Ferran Sánchez-Reus, Antonio Rezusta, Anuradha Chowdhary, Saad J. Taj-Aldeen, Maiken C. Arendrup, Salvatore Oliveri, Dimitrios P. Kontoyiannis, Ana Alastruey-Izquierdo, Katrien Lagrou, Giuliana Lo Cascio, Jacques F. Meis, Walter Buzina, Claudio Farina, Miranda Drogari-Apiranthitou, Anna Grancini, Anna M. Tortorano, Birgit Willinger, Axel Hamprecht, Elizabeth Johnson, Lena Klingspor, Valentina Arsic-Arsenijevic, Oliver A. Cornely, Joseph Meletiadis, Wolfgang Prammer, Vivian Tullio, Jörg-Janne Vehreschild, Laura Trovato, Russell E. Lewis, Esther Segal, Peter-Michael Rath, Petr Hamal, Manuel Rodriguez-Iglesias, Emmanuel Roilides, Sevtap Arikan-Akdagli, Arunaloke Chakrabarti, Arnaldo L. Colombo, Mariana S. Fernández, M. Teresa Martin-Gomez, Hamid Badali, Georgios Petrikkos, Nikolai Klimko, Sebastian M. Heimann, Omrum Uzun, Maryam Roudbary, Sonia de la Fuente, Jos Houbraken, Brigitte Risslegger, Cornelia Lass-Flörl, Michaela Lackner
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
Objectives: Invasive mold infections associated with Aspergillus species are a significant cause of mortality in immunocompromised patients. The most frequently occurring aetiological pathogens are members of the Aspergillus section Fumigati followed
Externí odkaz:
https://doaj.org/article/e8c31ea6b1384d07bc983f8ccddcd9bb
Publikováno v:
Medical Mycology Case Reports, Vol 6, Iss C, Pp 6-9 (2014)
A patient with Candida spondylitis failed two weeks of fluconazole combined with caspofungin, and the infection relapsed despite six weeks of liposomal amphotericin B followed by two months of fluconazole. Six months therapy with high dose liposomal
Externí odkaz:
https://doaj.org/article/9146b3e2fca344dc8544e3660c7f7b2d
Autor:
Susan J. Howard, Dasa Cerar, Michael J. Anderson, Ahmed Albarrag, Matthew C. Fisher, Alessandro C. Pasqualotto, Michel Laverdiere, Maiken C. Arendrup, David S. Perlin, David W. Denning
Publikováno v:
Emerging Infectious Diseases, Vol 15, Iss 7, Pp 1068-1076 (2009)
Azoles are the mainstay of oral therapy for aspergillosis. Azole resistance in Aspergillus has been reported infrequently. The first resistant isolate was detected in 1999 in Manchester, UK. In a clinical collection of 519 A. fumigatus isolates, the
Externí odkaz:
https://doaj.org/article/a2dc8fe2f41f416d9909c5fe67c1cd06
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 1, Pp 158-159 (2016)
Externí odkaz:
https://doaj.org/article/e9967b01c06d45aabcc36249a2b2b132
Publikováno v:
Journal of Antimicrobial Chemotherapy, 78(6), 1386-1394. Oxford University Press
Background The CLSI breakpoint for micafungin and Candida albicans is 0.25 mg/L, higher than the CLSI epidemiological cut-off value (0.03 mg/L) whereas the EUCAST values are identical (0.016 mg/L). We developed a novel in vitro dialysis-diffusion pha